Adalimumab for Inflammatory Osteoarthritis

NCT00686439 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-06-14

No results posted yet for this study

Summary

We will conduct a pilot study of the effectiveness of adalimumab for inflammatory osteoarthritis.

Conditions

Interventions

DRUG

adalimumab

subcutaneous injection 40mg on alternate weeks

DRUG

adalimumab

subcutaneous injection 40mg every other week

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • walter p maksymowych, FRCP · University of Alberta

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00686439 on ClinicalTrials.gov